Skip to main content
Premium Trial:

Request an Annual Quote

Steve Lombardi, Karl Steiner

Helicos announced Steve Lombardi as the company's chief executive officer effective immediately. Lombardi succeeds Stan Lapidus who will continue as chairman of the board of Helicos.
Lombardi joined Helicos in June 2006 as senior vice president of sales and marketing. He was promoted to executive vice president and chief operating officer and subsequently was named president and chief operating officer in October 2007.
During the 1990s, Lombardi was vice president of Applied Biosystems' DNA sequencing and genetic analysis business unit. He was also senior vice president at Affymetrix, serving in executive positions for corporate development and various commercial roles.

Karl Steiner has been named associate provost for interdisciplinary research initiatives at the University of Delaware effective Sept. 1.
Steiner is currently the associate director of the Delaware Biotechnology Institute and a professor of electrical and computer engineering.
Steiner has served as the program coordinator for the NIH-IDeA Network of Biomedical Research Excellence program since its establishment in 2001 and has directed the bioinformatics efforts launched under the INBRE program.

Steiner received his doctorate in engineering from the University of Kaiserslautern in Germany and his master's degree in electrical and computer engineering from the University of Delaware.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.